Dual-Tracer Assessment of Dynamic Changes in Reoxygenation and Proliferation Decrease During Fractionated Radiotherapy in Murine Tumors.
Wenjing Yu,Xiaoyu Su,Dan Zhang,Feng Qiao,Hui Wang,Jinhui Jiang,Huiqin Xu
DOI: https://doi.org/10.3389/fonc.2020.01046
IF: 4.7
2020-01-01
Frontiers in Oncology
Abstract:Objective:The present work aimed to assess reoxygenation and tumor inhibition during fractionated radiotherapy (FRT) in murine tumors using(18)F-fluoromisonidazole (F-18-FMISO) and(18)F-fluorothymidine (F-18-FLT) based micro positron emission tomography/computed tomography (PET/CT). Materials and Methods:A nude mouse xenograft model was established with the head and neck squamous carcinoma cell (FaDu), followed by administration of FRT. Imaging was carried out with both(18)F-FMISO and(18)F-FLT PET/CT, prior to FRT (Pre-FRT, 0 Gy), during FRT (Inter-FRT, 21 Gy), and after FRT (Post-FRT, 40 Gy). The maximum standardized uptake (SUVmax) and tumor-to-normal muscle ratio (TNR) were determined in regions of interest (ROIs) in(18)F-FMISO and(18)F-FLT PET/CT images. Then, hypoxic (HV) and proliferative tumor (PTV) volumes obtained by PET/CT were analyzed. Immunohistochemistry was performed to analyze the changes of hypoxia-inducible factor- (HIF)-1 alpha, carbonic anhydrase 9 (CAIX), Ki67 and proliferating cell nuclear antigen (PCNA). Associations of the levels of these biomarkers with PET/CT parameters were analyzed. Results:F-18-FMISO PET/CT demonstrated markedly elevated reduction rates of SUVmax (30.3 vs. 14.5%,p= 0.012), TNR (27.9 vs. 18.3%,p= 0.032) and HV (85.0 vs. 71.4%,p= 0.047) from Pre-FRT to Inter-FRT compared with values from Inter-FRT to Post-FRT. Meanwhile, PTV reduction rate in(18)F-FLT PET/CT from Pre-FRT to Inter-FRT was significantly decreased compared with that from Inter-FRT to Post-FRT (21.2 vs. 82.7%,p= 0.012). Tumor HIF-1 alpha, CAIX, Ki67, and PCNA amounts were continuously down-regulated during radiotherapy. TNR (FMISO) showed significant correlations with HIF-1 alpha (r= 0.692,p= 0.015) and CAIX (r= 0.801,p= 0.006) amounts in xenografts, while associations of SUVmax (FMISO) with hypoxia markers were weak (r= 0.418,p= 0.041 andr= 0.389,p= 0.037, respectively). SUVmax (FLT) was significantly correlated with Ki67 (r= 0.792,p= 0.003) and PCNA (r= 0.837,p= 0.004). Conclusions:Tumor reoxygenation occurs early during radiotherapy, while inhibition of cell proliferation by tumoricidal effects mainly takes place gradually with the course of radiotherapy.F-18-FMISO and(18)F-FLT PET/CT are sensitive and non-invasive tools for the monitoring of tumor reoxygenation and proliferation during radiotherapy.